In July 2025, the pharmaceutical sector in Ukraine demonstrates resilience, strategic renewal, and readiness to respond to the challenges of innovation. Understanding these trends is the key to implementing effective solutions in your practice.
The NGO Management Sciences for Health has presented its monthly SAFEMed report, which reveals achievements in improving logistics, transparency in procurement, and improving the availability of medicines for the treatment of HIV, tuberculosis, COVID-19, and chronic diseases. The initiative strengthens trust in the pharmacy market and lays the foundation for fair pharmaceutical action.
The global scientific project “From Legacy to Leadership” together with the Max Planck Institute is launching an 18-month plan to modernize Ukraine’s pharmaceutical industry based on the Soviet industrial system. The goal is to use the powerful scientific and production potential to integrate into European standards, stimulating innovative exports and national sustainability.
The world-renowned WHO and UNODC have published a report on the dangers of contamination of pharmaceutical excipients (excipients) with diethylene glycol and ethylene glycol — toxic substances that endanger the lives of children in countries with weak control systems. Weakening the flora of the pharmaceutical world means that the foundation for reliability and control has been laid.
Cutting-edge research in AI pharmacology is creating the concept of “programmable virtual humans”—digital models that simulate the body’s response to drugs at the cellular and systems levels, significantly accelerating discovery and reducing risk. This is a chance for Ukraine to become a full-fledged player in digital biopharma.
In July, data on Luvesilocin, a potential psychedelic prodrug of 4-HO-DiPT in phase II clinical trials, gained traction. Its goal is to treat postpartum depression, which is especially relevant in Ukraine, where this condition is often overlooked by the healthcare system.
Technical analysis of depolarization (TDP) in an ERVO stack. Economics of organic waste processing and EROEI indicators. Expert assessment by Oleksandr Mospanenko.
Resistance analysis of ESKAPE strains.. Methodology by A. Demchenko for C-level Pharma.
Scientific justification for the reclamation of technozems. Bioremediation based on glauconite according to patents of the AVELIFE Institute. Expert assessment by Timur Levda for agricultural holdings
